Construction of Colitis Model in C57 Mice: Experimental Protocol and Evaluation

The construction of a colitis model in C57 mice serves as a critical experimental platform for investigating the pathogenesis of Inflammatory Bowel Disease (IBD) and developing novel therapeutic strategies. This guide provides a comprehensive technical protocol for establishing the Dextran Sulfate Sodium (DSS)-induced colitis model in C57BL/6 mice, focusing on reproducibility and standard evaluation metrics. By adhering to these rigorous methodologies, researchers can effectively simulate human ulcerative colitis for preclinical studies.

Technical Overview

The C57BL/6 mouse strain is the most widely used background strain for generating genetically modified mice, making it a primary choice for colitis research. The Dextran Sulfate Sodium (DSS) model is the standard chemical method used to induce acute and chronic colitis in these subjects. DSS is a sulfated polysaccharide that disrupts the intestinal mucosal barrier, leading to the translocation of bacteria and subsequent activation of the inflammatory cascade. This model is highly valued for its simplicity, rapid onset, and clinical resemblance to human ulcerative colitis.

The severity of the induced colitis is influenced by several variables, including the molecular weight of the DSS, the concentration used, and the specific microbiological status of the C57BL/6 colony. Successful construction of this model requires precise control of administration protocols and systematic monitoring of physiological changes.

Testing Samples

Experimental Animals

Specific Pathogen-Free (SPF) grade C57BL/6 mice are required. Typically, male or female mice aged 6 to 10 weeks are selected for the experiment. The body weight of the mice usually ranges from 18g to 22g at the start of the induction period. Animals must be acclimatized to the laboratory environment for at least one week prior to the start of the experiment to minimize stress-related variables.

Inducing Agents

Dextran Sulfate Sodium (DSS) is the primary reagent. It is available in various molecular weights, typically ranging from 36kDa to 50kDa. The reagent is white or off-white powder, highly hygroscopic, and must be dissolved in sterile drinking water to the desired concentration before use.

Testing Items

The evaluation of the C57 mouse colitis model involves a combination of physiological, morphological, and molecular parameters. These items ensure the model accurately reflects the inflammatory state.

• Disease Activity Index (DAI): A composite score based on weight loss, stool consistency, and the presence of fecal blood.
• Colon Length Measurement: A macroscopic indicator where significant shortening of the colon correlates with the severity of inflammation.
• Body Weight Monitoring: Daily weight measurements are crucial for tracking disease progression.
• Spleen Weight: Splenomegaly is often observed as a systemic response to severe intestinal inflammation.
• Histopathological Scoring: Evaluation of mucosal architecture, inflammatory cell infiltration, and crypt damage using light microscopy.
• Myeloperoxidase (MPO) Activity: An enzymatic marker for neutrophil accumulation in the intestinal tissue.

Testing Methods

Model Construction Procedure

The acute colitis model is typically established over a 7-day cycle. The DSS powder is dissolved in autoclaved drinking water at a specific concentration, usually between 2% and 3.5% (w/v), depending on the batch potency and desired severity. The solution must be prepared fresh every 2 to 3 days to prevent degradation. Mice in the experimental group receive the DSS solution ad libitum as their sole source of drinking water, while the control group receives normal drinking water.

Daily Monitoring

Researchers must monitor the mice daily for signs of distress, weight loss, and diarrhea. The Disease Activity Index (DAI) is calculated using a standard scoring system. For instance, weight loss is scored on a scale of 0 to 4 (0 for no loss, 4 for >20% loss). Stool consistency and rectal bleeding are similarly scored. This quantitative data allows for the tracking of disease kinetics.

Sample Collection and Processing

On the termination day, mice are euthanized humanely. The colon is excised from the ileocecal junction to the anus, cleaned of adipose tissue, and measured. A shortened colon is a hallmark of severe colitis. The colon is then opened longitudinally. One section is fixed in 4% paraformaldehyde for histology, while other sections are snap-frozen in liquid nitrogen for molecular analysis such as ELISA, RT-PCR, or Western blotting to detect inflammatory cytokines like TNF-alpha, IL-1beta, and IL-6.

Applications

The C57 mouse colitis model is a versatile tool in biomedical research with applications spanning basic science and drug discovery.

• Mechanism of IBD Pathogenesis: Investigating the role of immune cells, cytokines, and the epithelial barrier in intestinal inflammation.
• Drug Efficacy Screening: Evaluating the therapeutic potential of small molecules, biologics, or natural products for ulcerative colitis treatment.
• Host-Microbiome Interaction: Studying how gut microbiota composition changes during inflammation and how it influences disease severity.
• Genetic Studies: Utilizing transgenic or knockout C57BL/6 mice to understand the function of specific genes in colitis susceptibility and progression.

FAQ

Why choose C57BL/6 mice over other strains?

C57BL/6 is the most common inbred strain used in laboratories. Its genome is fully sequenced, and it is the background strain for the majority of transgenic and knockout models. This allows researchers to easily combine disease models with genetic modifications. However, C57BL/6 mice can be relatively resistant to DSS compared to strains like BALB/c, often requiring a higher concentration of DSS to induce severe colitis.

What factors affect the reproducibility of the model?

Reproducibility can be affected by the molecular weight of the DSS, the specific manufacturer, the water consumption of the mice, and the gut microbiota profile. To ensure consistency, it is critical to use DSS from the same lot number for a single study, use age-matched mice, and maintain consistent housing conditions.

How is the difference between acute and chronic models distinguished?

The acute model involves a single cycle of DSS administration (usually 5-7 days) followed by normal water or immediate analysis. A chronic model involves multiple cycles of DSS administration interspersed with recovery periods (e.g., 5 days DSS, 14 days water, repeated). The chronic model better mimics the relapsing-remitting nature of human Crohn's disease or severe ulcerative colitis.